ing used 1 . In chemotherapy, alkylation agents, mitotic inhibitors and antimetabolites are used either alone or in combination with each other. In simple terms, a selective drug must be active on cancer cells but inactive in normal cells. But the differences between normal and cancer cells is quite little and not qualitative so that its hard to find an exploitable mechanism 2 . Purine and pyrimidine analog drugs such as 5-fluorouracil and 6-mercaptopurine have been widely used in succesful treatment of cancer disease 3 . Many nitrogen containing heterocylic compounds such as 1,2,4-triazines have been constitutes medicinal chemists' interest area in cancer theraphy 4, 5 . The potential anticancer-cytostatic effects of 1,2,4-triazine derivatives were widely studied and reported to have promising activity [6] [7] [8] [9] [10] [11] [12] .
5-Lipoxygenase (5-LOX) is a crucial enzyme which catalyses biosynthesis of leukotrienes in the arachidonic acid (AA) cascade. Variable leukotriene levels were reported in different diseases like cardiovascular diseases and certain types of cancer as well as asthma, allergic rhinitis 13 . In particular, 5-LOX have been found to be up-regulated in many cancer cell lines, which results in promoting the development of carcinogenesis. Inhibition of LOX enzyme could be a subsidiary mechanism for down-regulation of tumors accordingly this approach enables a rational concept for the design of more effective antitumor agents 14 . Accordingly, we aimed to synthesize 1-[4-(5,6-bis-(4-substituted phenyl)-1,2,4-triazin-3-yl)piperazin-1-yl]-2-[(1H-(benz)imidazol/thiazole/oxazole-2-yl)thio] ethan-1-one derivatives (1-9) for evaluating anticancer activity by following a study reported before a number of derivatives with similar structures 15 . The structure elucidation was carried out by spectroscopic techniques and in vitro anticancer activities of compounds were evaluated using MTT technique on MCF-7 and C6 tumor cell lines. The lipooxygenase (LOX) enzyme inhibitory activiy of the compounds were also studied.
METHODOLOGY

Chemistry
Synthesis and characterization
All needed chemicals were purchased from Sigma-Aldrich (Sigma-Aldrich Corp., St. Louis, MO, USA). All melting points (m.p.) were determined by MP90 digital melting point apparatus (Mettler Toledo, OH) and were uncorrected. All the reactions were monitored by thin-layer chromatography (TLC) using Silica Gel 60 F254 TLC plates (Merck KGaA, Darmstadt, Germany). Spectroscopic data were recorded with the following instruments: a Bruker Tensor 27 IR spectrophotometer; 1 H NMR (nuclear magnetic resonance) Bruker DPX-300 FT-NMR spectrometer, 13 C NMR, Bruker DPX 75 MHz spectrometer (Bruker Bioscience, Billerica, MA, USA); M+1 peaks were determined by Shimadzu LC/MS ITTOF system (Shimadzu, Tokyo, Japan). The synthesis of three intermediate products, 2-chloro-1-[4-(5,6-bis-(4-substituted phenyl)-1,2,4-triazin-3-yl)piperazin-1-yl] ethanones (IIIa-c) was carried out by the following study of Demirayak and coworkers 15 .
General procedure for the synthesis of the final compounds (1-9)
Equal moles of halogenated compounds (IIIa-c), 2-mercapto(benz)imidazole/ thiazole/oxazole and potassium carbonate were stirred in acetone for 5 h. At the end of the reaction, the solvent was evaporated and the residue was treated with water. The obtained precipitation was filtered and it recrystallized from ethanol after dryness.
To realize the characterization and identification of compounds, Infrared-1 H-NMR, 13 C-NMR and mass spectroscopy methods were used. Melting points were determined by using stuart melting apparatus. Yields and elemental analysis also calculated for each compound. 
1-[4-(5,6-Bis-(4-methoxyphenyl)-1,2,4-triazin-3-yl)piperazin-1-yl]-2-[(1H-benzimidazol-2-yl)thio]ethan-1-one (4):
1-[4-(5,6-Bis-(4-chlorophenyl)-1,2,4-triazin-3-yl)piperazin-1-yl]-2-[(1H-benzimidazol-2-yl)thio]ethan-1-one (7):
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1-[4-(5,6-Bis-(4-chlorophenyl)-1,2,4-triazin-3-yl)piperazin-1-yl]-2-[(1H-benzoxazol-2-yl)thio]ethan-1-one (8):
Biochemistry
Cytotoxicity
For measuring the cytotoxic activity of compounds, MTT method (tetrazolium salt (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was applied on MCF-7 breast adenocarcinoma and C6 rat glioma cell lines. The instruction in literature was followed to carry out experiments. To produce the cells, cell lines incubated in 96 well-plates for 24 h at 37 0 C. Then, 20 µL of MTT solution (5 mg/mL MTT in PBS) was added for each well and incubation was continued for more 2 hours at 37 0 C 16, 17 . Before measuring the absorbance by ELISA reader (OD 570 nm), dissolving of crystals using DMSO (200 µL) was needed. Absorbance values were read and percentage of survival cells was calculated compared medium. All measurements were measured triplicate 18 .
In vitro lipoxygenase (LOX) inhibition assay LOX inhibition activity was measured by a modified the spectrophotometric method developed by Baylac and Racine 19 . LOX (1.13.11.12, type I-B, Soybean), linoleic acid and all required chemicals were purchased from Sigma-Aldrich. Potassium phosphate buffer (1,94 mL; 100mM; pH 9.0), 40 µL of test compound solution and 20 µL of lipoxygenase solution were mixed and incubated for 10 min at 25 °C. The reaction was then initiated by the addition of 10 µL linoleic acid solution, the change of absorbance at 234 nm was followed for 10 min. Test compounds and positive control Nordihydroguaiaretic acid (NDGA) were dissolved in methanol. All spectrum measurements were carried out in quartz cuvette avoiding material absorbance interference.
The concentration of test compounds which provided 50% inhibition (IC 50 ) of LOX enzyme was calculated and the experiments were performed triplicate for each concentration. For eliminating faults and non-enzymatic hydrolysis, blanks were compared without test compounds. Alteration in absorbance was recorded comparingly between with and without test compounds for determining enzyme inhibition activity and the results were given in percentages and standard deviations (SD+) were performed using Microsoft Office Excel 2013 program.
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RESULTS AND DISCUSSION
Chemistry
The synthesis of title compounds were carried out by a multi-step synthetic procedure according to previously reported study of us C-NMR spectra of the compounds, signals belonging to aliphatic carbon atoms were assigned at about 21.28-55.80 ppm; and signals for aromatic carbon atoms were observed at 101.68-165.75 ppm. The carbonyl carbon of amide group was seen at about 166 ppm. In mass spectroscopy, [M+H] + peaks were established in accordance with the molecular weights of the compounds.
Biology
The cytotoxic activity of nine triazine compounds (1-9) were determined against C6 rat glioma and MCF-7 breast adenocarcinoma cell lines and results were summarized in Table 1 . IC 50 values were calculated in between 9.5-500 µg/mL. Compound 4 (IC 50 =21.0 µg/mL) was found as the most active compound even more than cisplatin against C6 cell line. Compound 6 was also exhibited good antiproliferative activity with a IC 50 value of 26.0 µg/mL which is very close to cisplatin (IC 50 =23.5 µg/mL). The IC 50 values could not be calculated for compounds 1, 3, 8 and 9 even if at the highest tested concentration which is 500 µg/ mL against C6 tumor cells. Against MCF-7 cell line, compound 5 showed the strongest cytotoxicity (IC 50 =9.5 µg/mL) which was higher than cisplatin. Com-pound 2 and 8 also showed good activity with IC 50 values of 58.33 and 51.67 µg/ mL, respectively. Two active compounds against C6 cells, compound 4 and 6 did not exhibite enough cytotoxic activity against MCF-7 cell line. Moreover, the lipooxygenase (LOX) inhibitory activity of the compounds were studied. None of the compounds showed LOX inhibition as much as standard drug nordihydroguaiaretic acid, even if IC 50 , the half maximal inhibitory concentration could not be calculated. At 100 µg/mL concentration, LOX inhibition percentages were identified for compounds 1 and 6 as 43.35% and 38.79%, respectively. The results revelaed that 1,2,4-triazine derivatives have considerable cytotoxic activity. As a follow up study from past to present studies, antiproliferative activity of the compounds are rational and it worths to design new compounds based on this substructure.
Scheme 1: The synthesis of the compounds. Reactants and reagents ; i: NaHCO 3 , CH 3 OH, reflux 3 h; ii: pyridine, reflux 6 h; iii: Et 3 N, DMF, r.t., 45 min; iv: K 2 CO 3 , Acetone, r.t., 5 h.
